-
Boulter stuns Rybakina to reach Queen's Club semi-finals
-
After historic rally, Knicks aim to subdue Spurs early
-
When Hockney told AFP about his lockdown 'blessing' in France
-
In partial victory, Blake Lively wins legal fees from Justin Baldoni
-
Trump calls US World Cup team before first match
-
Partey refused entry to Canada for Ghana's World Cup opener
-
EU says to resume membership talks with Ukraine on Monday
-
'We're over it': Wemby says Spurs focused on game five after historic loss
-
Bruce Springsteen music center set to open in New Jersey
-
Cuba opens more sectors to private business
-
McTominay 'ready to go' for Scotland World Cup opener
-
Ghana World Cup player Partey, facing rape trial in UK, denied Canada visa: FIFA
-
Plane trouble delays pope's return after migrant-focused Spain visit
-
Canada's World Cup moment arrives at home
-
World's first gig economy treaty adopted at the ILO
-
Ireland-Israel football fixture to be played at neutral venue
-
World Cup struggles to ignite US excitement
-
US appellate court upholds Sam Bankman-Fried criminal sentence
-
Premier League changes hair-pulling punishment for new season
-
World amateur No.1 golfer Koivun to turn pro after US Open
-
McLaren's Norris pips Russell in second Barcelona F1 practice
-
Fans hope 'Orange Street' guides Dutch to World Cup victory
-
Florence's Giotto frescoes restored to glory after renovation
-
UK faces hard choices over military spending: analysts
-
Whole England squad must feel 'loved' at World Cup: Bellingham
-
Wall Street climbs as SpaceX shares launch, oil slides on Mideast deal hopes
-
Players welcome 'step forward' after Wimbledon prize money increase
-
Contemporary art giant David Hockney dies aged 88
-
France bids farewell to girl, 11, whose killing sparked outrage
-
Van Gils claims Auvergne Tour stage as Tuckwell moves into overall lead
-
Pele's 1958 World Cup winners' medal set to fetch £500,000
-
Ebola spreading into new areas in northeast DR Congo: WHO
-
African, Asian experts denied EU visas for major midwives summit
-
Kennedy Center board, Justice Dept appeal order to remove Trump's name
-
Former world champion Tsegay banned over doping violation
-
Wall Street wobbles as SpaceX shares launch, oil slides on Mideast deal hopes
-
SpaceX lifts off in record Wall Street debut
-
US deportation flight carrying Iranians en route to C.African Republic
-
Afghans scrap protest plans as Herat city under tight security
-
'I don't want to limit myself': Chinese star Xin Zhilei on new experiences
-
New Zealand great Williamson says 'right time' to retire from international cricket
-
Ronaldo 'very positive' as Portugal head for World Cup
-
Mercedes' Russell quickest in opening Barcelona F1 practice
-
At a Libyan university once ravaged by war, students dream again
-
O'Callaghan and Short star at Australian swim trials
-
Kenya mourns schoolgirls killed in suspected dorm arson attack
-
Iran insists on nuclear enrichment under any deal with US
-
Stocks rally, oil slides on Mideast deal hopes
-
COP31 hosts urged to 'lead by example' on fossil fuels
-
Alpine's Gasly reinstated to Monaco Grand Prix podium
Trump announces departure of food and drug regulation chief
President Donald Trump said Tuesday his US Food and Drug Administration chief, Marty Makary, is leaving his post, a departure that follows weeks of political tumult at the powerful agency.
During his tenure atop the sprawling body responsible for overseeing vaccines, medicine and food, Makary managed to upset figures across industry, politics and public health over a range of issues, and most recently faced pressure from the Republican president to sign off on fruit-flavored vapes.
"Marty is a terrific guy, but he's going to go on, and he's going to lead a good life," Trump said, speaking to journalists who pressed him on the reported resignation that comes after weeks of rumors that the president planned to fire his FDA commissioner.
Makary, a surgeon and former Fox News contributor, made waves during the Covid-19 pandemic as an outspoken critic of the medical establishment and the health measures of the time.
He took over the FDA promising reform. He leaves just over a year later, facing criticism from all angles, including from pharmaceutical executives, tobacco lobbyists, and anti-abortion activists.
Conservatives against the abortion pill mifepristone accuse Makary of taking too long to complete and issue a review of the drug that's been FDA-approved for 25 years, but which they continue to target.
The Trump administration meanwhile forged ahead with a policy allowing for the sale of flavored e-cigarettes despite resistance from Makary, who had voiced concern over the appeal of the vapes to youth.
Many pharmaceutical executives said Makary's initiatives to shake up the drug review process had only created more problems.
And public health leaders accused him of catering to anti-vaccine activists after the FDA put out an unsupported memo claiming deaths linked to the Covid-19 vaccine.
It's the latest in a string of shake-ups at the health department overseen by noted vaccine skeptic Robert F. Kennedy Jr, with figures seen as more conventional put forth as nominees to be surgeon general as well as helm the Centers for Disease Control and Prevention.
X.Brito--PC